Reggiani, Francesco
 Distribuzione geografica
Continente #
AS - Asia 1.229
NA - Nord America 1.121
EU - Europa 329
SA - Sud America 179
AF - Africa 31
OC - Oceania 4
Totale 2.893
Nazione #
US - Stati Uniti d'America 1.081
SG - Singapore 689
CN - Cina 294
BR - Brasile 135
VN - Vietnam 121
IT - Italia 103
HK - Hong Kong 39
DE - Germania 30
FI - Finlandia 29
IE - Irlanda 27
IN - India 25
GB - Regno Unito 23
MK - Macedonia 20
AR - Argentina 19
FR - Francia 18
CA - Canada 17
MX - Messico 16
NL - Olanda 15
PL - Polonia 13
BD - Bangladesh 11
PH - Filippine 10
RU - Federazione Russa 8
ES - Italia 7
UA - Ucraina 7
ZA - Sudafrica 7
EC - Ecuador 6
NG - Nigeria 6
PK - Pakistan 6
AT - Austria 5
CO - Colombia 5
MA - Marocco 5
PE - Perù 5
TN - Tunisia 5
AU - Australia 4
IQ - Iraq 4
LV - Lettonia 4
SA - Arabia Saudita 4
SE - Svezia 4
TR - Turchia 4
BB - Barbados 3
CL - Cile 3
JP - Giappone 3
VE - Venezuela 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
ET - Etiopia 2
HU - Ungheria 2
ID - Indonesia 2
IL - Israele 2
JO - Giordania 2
LT - Lituania 2
PY - Paraguay 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BS - Bahamas 1
BY - Bielorussia 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MU - Mauritius 1
MY - Malesia 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UG - Uganda 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 2.893
Città #
Singapore 331
Ashburn 187
San Jose 184
Shanghai 118
The Dalles 95
Beijing 83
Boardman 72
Dallas 59
New York 47
Ho Chi Minh City 42
Hong Kong 37
Hanoi 31
Helsinki 29
Milan 28
Los Angeles 27
Santa Clara 27
Chandler 26
Dublin 26
Naples 24
Council Bluffs 17
Phoenix 16
São Paulo 14
Rio de Janeiro 10
Warsaw 10
Wilmington 10
Orem 9
Skopje 9
Brooklyn 8
Montreal 8
Paris 8
Washington 8
London 7
Amsterdam 6
Chennai 6
Frankfurt am Main 6
Haiphong 6
Mexico City 6
Benin City 5
Bitola 5
Boston 5
Cusco 5
Da Nang 5
Seattle 5
Assago 4
Buffalo 4
Charlotte 4
Johannesburg 4
Mumbai 4
Riga 4
San Francisco 4
Buenos Aires 3
Falkenstein 3
Fort Worth 3
Houston 3
Hải Dương 3
Lawrence 3
Medellín 3
Ninh Bình 3
Nuremberg 3
Olongapo City 3
Prilep 3
Princeton 3
Prineville 3
Pune 3
Rabat 3
Rome 3
San Mateo 3
Springfield 3
Sydney 3
Tampa 3
Tokyo 3
Addis Ababa 2
Amman 2
Atlanta 2
Baku 2
Belo Horizonte 2
Bengaluru 2
Bogovinje 2
Bridgetown 2
Camden 2
Chandigarh 2
Cuenca 2
Delhi 2
Denver 2
Gdansk 2
Glasgow 2
Hillsboro 2
Imperatriz 2
Irene 2
Karachi 2
Kyiv 2
Las Pinas 2
Lauterbourg 2
Macaé 2
Madrid 2
Parauapebas 2
Pasadena 2
Philadelphia 2
Porto Alegre 2
Recife 2
Totale 1.816
Nome #
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 211
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 132
Herpes zoster in lupus nephritis: experience on 292 patients followed up for 15 years 84
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 76
Goodpasture syndrome and anti-glomerular basement membrane disease 72
Low testosterone predicts hypoxemic respiratory insufficiency and mortality in patients with COVID-19 disease: another piece in the COVID puzzle 72
Changing Phenotypes and Clinical Outcomes Over Time in Microscopic Polyangiitis 71
Long-term kidney outcome of patients with rheumatological diseases and antineutrophil cytoplasmic antibody-glomerulonephritis: comparison with a primitive ANCA-glomerulonephritis cohort 70
Beyond ISN/RPS Lupus Nephritis Classification: Adding Chronicity Index to Clinical Variables Predicts Kidney Survival 70
Comparative Analysis of Antithrombotic Therapy Outcomes in Mild Traumatic Brain-Injury Patients: A Focus on Bleeding Risk and Hospital-Stay Duration 70
A phase 2 randomized, double-blinded, placebo-controlled, multicenter trial evaluating the efficacy and safety of raloxifene for patients with mild to moderate COVID-19 64
Cardiovascular Risk after Kidney Transplantation: Causes and Current Approaches to a Relevant Burden 60
Autosomal Dominant Polycystic Kidney Disease: Is There a Role for Autophagy? 60
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 60
Prevalence and clinical significance of ANCA positivity in lupus nephritis: a case series of 116 patients and literature review 58
Blood Thiol Redox State in Chronic Kidney Disease 58
Anti-C1q antibodies: a biomarker for diagnosis and management of lupus nephritis. A narrative review 57
Monoclonal gammopathy in lupus nephritis 55
Assessment of glutathione/glutathione disulphide ratio and S-glutathionylated proteins in human blood, solid tissues, and cultured cells 55
The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome 55
Delayed Graft Function in Kidney Transplant: Risk Factors, Consequences and Prevention Strategies 53
Subjective Global Assessment-Dialysis Malnutrition Score and cardiovascular risk in hemodialysis patients: an observational cohort study 51
Kinetics of the Cell Cycle Arrest Biomarkers (TIMP2 and IGFBP7) for the Diagnosis of Acute Kidney Injury in Critically Ill COVID-19 Patients 51
Plasma protein carbonyls as biomarkers of oxidative stress in chronic kidney disease, dialysis, and transplantation 50
Anti-C1Q monitoring predicts relapses of lupus nephritis 50
Predictors of increase in chronicity index and of kidney function impairment at repeat biopsy in lupus nephritis 49
Plasma protein-bound di-tyrosines as biomarkers of oxidative stress in end stage renal disease patients on maintenance haemodialysis 49
Advanced oxidation protein products in nondiabetic end stage renal disease patients on maintenance haemodialysis 49
HCV-negative mixed cryoglobulinemic glomerulonephritis and solid malignancy: A case report and review of the literature 48
Dysphagia screening post-stroke: systematic review 48
Neurological Counterparts of Hyponatremia: Pathological Mechanisms and Clinical Manifestations 46
Autophagy: A Silent Protagonist in Kidney Transplantation 46
Renal involvement in eosinophilic granulomatosis with polyangiitis 44
Enhancing clinical nutrition education for healthcare professionals: Engagement through active learning methodologies 44
Switching Patients with Type 1 Diabetes to Insulin Degludec from Other Basal Insulins: Real-World Data of Effectiveness and Safety 44
Focal segmental glomerular sclerosis: do not overlook the role of immune response 43
Assessment of malnutrition risk in post-stroke patients: a systematic literature review 43
Old and new calcineurin inhibitors in lupus nephritis 43
Preliminary experience on the use of sucrosomial iron in hemodialysis: focus on safety, hemoglobin maintenance and oxidative stress 42
Ursodeoxycholic Acid Does Not Improve COVID-19 Outcome in Hospitalized Patients 42
Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety 41
Treatment strategies for ANCA-associated vasculitides: from standard protocols to future horizons 39
Impact of Mayo Adhesive Probability score and BMI on renal functional decline after robotic assisted partial nephrectomy 39
Plasma protein carbonylation in haemodialysed patients: Focus on diabetes and gender 38
Erdheim-Chester disease: From palliative care to targeted treatment 38
Hospital Malnutrition in the Medicine and Neurology Departments: A Complex Challenge 38
Improvement of Erdheim-Chester disease-related renal failure after treatment with anakinra 37
Plasma protein thiolation index (PTI) as a biomarker of thiol-specific oxidative stress in haemodialyzed patients 36
Autophagy and podocytopathy 35
Kidney Involvement in Systemic Sclerosis 35
Integrated protocol for the prevention and treatment of skin ulcers in patients with end-stage renal disease 34
Renal sarcoidosis 32
Immune-mediating and immunosuppressive pharmacotherapies for proliferative lupus nephritis 29
Clinical presentation, outcomes and risk of relapses of lupus podocytopathy in a multicentre Italian cohort 23
Clinical and immunological biomarkers can identify proliferative changes and predict renal flares in lupus nephritis 14
Scaling up frailty: psychometric validation of the functional limitations and geriatric syndromes frailty questionnaire—a new tool for uniformly classifying vulnerable hospital patients 8
Long-term prognosis of lupus nephritis: comparison between pediatric, adult, and advanced age onset 6
Malignancies in lupus nephritis: a retrospective cohort study on epidemiology and risk factors 4
Different clusters in patients with lupus podocytopathy identified by clinical-pathological characteristics 3
Diagnostic challenge of high vitamin B12 levels: a case report and review of the literature 2
Isolated C3 hypocomplementemia as an early predictor of chronic kidney disease in lupus nephritis 2
Pain, quality of life, work ability and psychosocial well-being in living kidney donors: A scoping review 2
Predictors of Long-term Response in Patients With Lupus Nephritis 2
Three years is the minimal effective duration of sustained clinical remission which prevents impaired kidney function and damage accrual in lupus nephritis 1
Editorial: Exploring the impact of biologics in nephrology: clinical advances and future perspectives 1
Totale 2.984
Categoria #
all - tutte 16.935
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.935


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113 0 0 0 0 0 0 0 0 0 0 0 13
2021/202222 0 1 1 2 0 0 1 2 1 3 10 1
2022/2023120 7 3 6 4 8 9 4 8 27 6 7 31
2023/2024460 38 11 68 48 20 47 61 44 17 8 40 58
2024/2025727 6 36 19 16 10 54 28 84 96 160 116 102
2025/20261.622 219 102 64 120 104 107 440 105 76 135 91 59
Totale 2.984